Public blog

Research programs of Mayo Clinic Comprehensive Cancer Center

Designated as a comprehensive cancer center by the National Cancer Institute, Mayo Clinic Comprehensive Cancer Center is defining new boundaries in possibility, focusing on patient-centered care, developing novel treatments, and bringing cancer research to communities.

With campuses in Phoenix/Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota, Mayo Clinic Comprehensive Cancer Center has a broad geographic reach, enabling it to serve diverse patient populations around the world. Among our exciting research success stories:

  • Advancing CAR-T cell therapy, enabling Mayo Clinic to become one of the first centers in the U.S. offering CAR-T cell therapy as a clinical treatment. Learn about the CAR-T Cell Therapy Program.
  • Driving research behind the Proton Beam Therapy Program at Mayo Clinic, which exclusively features intensity-modulated proton beam therapy with pencil beam scanning. Learn about the program.
  • Developing Cologuard, the stool DNA test co-developed by Mayo Clinic and Exact Sciences Corp. and now a colorectal cancer screening tool recommended by the U.S. Preventive Services Task Force. Read more about the stool DNA test.
  • Leading the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) collaboration study, which showed that for patients with low-risk stage III colon cancer, a shortened course of oxaliplatin-based chemotherapy after surgery was associated with reduced side effects compared with the traditional course of chemotherapy and was just as effective.

Related information